Michael Atkins
Vermogen: 6 489 $ op 31-05-2026
Vermogen: 6 489 $ op 31-05-2026
Michael B. Atkins currently holds the positions of Director at Melanoma Research Foundation, Independent Director at Werewolf Therapeutics, Inc. since 2024, President at Society For Immunotherapy of Cancer, and Professor at Harvard Medical School since 2002.
Dr. Atkins completed undergraduate education at Tufts University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2025 | 14.419 ( 0,03% ) | 6 489 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Directeur/Bestuurslid | 04-01-2024 |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Directeur/Bestuurslid | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2002 |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Commercial Services |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau